The target is confirmed and unambiguous. UniProt Q88DF6 (gene nadE, ordered locus PP_4869) from Pseudomonas putida strain KT2440 (ATCC 47054 / DSM 6125) is a 275-residue, ~29.3 kDa protein annotated as NH(3)-dependent NAD(+) synthetase, EC 6.3.1.5 (HAMAP rule MF_00193). It belongs to the NAD synthetase family (Pfam PF02540; InterPro IPR003694 "NAD_synthase", IPR022926 "NH(3)-dep_NAD(+)_synth", IPR022310 "NAD/GMP_synthase", IPR014729 Rossmann-like α/β/α fold). The gene symbol, EC number, protein family and domain content are internally consistent and match the well-characterized bacterial NadE family. Function is described below from primary literature on the enzyme family (chiefly the near-identical Bacillus subtilis enzyme, whose structure/mechanism is solved to atomic resolution) combined with the organism-specific UniProt annotation; no gene-symbol ambiguity was encountered.
NadE (Q88DF6) is the enzyme that catalyzes the final, committed step of NAD⁺ biosynthesis. It performs the ATP-dependent amidation of nicotinic acid adenine dinucleotide (NaAD, "deamido-NAD⁺") to NAD⁺, using ammonia (NH₄⁺) as the nitrogen donor:
deamido-NAD⁺ + NH₄⁺ + ATP → NAD⁺ + AMP + diphosphate (PPi) + H⁺ (EC 6.3.1.5)
It is a cytoplasmic homodimer that acts through a two-step mechanism via a covalent NaAD-adenylate intermediate, and it is the single terminal enzyme on which both the de novo and salvage NAD⁺ pathways converge — making it central to redox metabolism and typically essential.
Reaction (from UniProt catalytic-activity annotation):
deamido-NAD⁺ + NH₄⁺ + ATP = AMP + diphosphate + NAD⁺ + H⁺ (EC 6.3.1.5).
Pathway position: "Cofactor biosynthesis; NAD⁺ biosynthesis; NAD⁺ from deamido-NAD⁺ (ammonia route): step 1/1" — i.e., NadE is the terminal step that installs the amide nitrogen that chemically distinguishes NAD⁺ from its precursor NaAD.
The final step of NAD⁺ biosynthesis "includes an amide transfer to nicotinic acid adenine dinucleotide (NaAD) catalyzed by NAD⁺ synthetase" (Symersky et al., 2002, PMID 12077433). The enzyme is ubiquitous and "transform[s] deamido-NAD⁺ into NAD⁺ by a two-step reaction" (Rizzi et al., 1998, PMID 9753692).
Substrate specificity / nitrogen-donor selectivity. Q88DF6 is a short-form, NH₃-dependent NAD synthetase: at 275 aa it consists of only the synthetase (Rossmann-like α/β/α) catalytic domain and lacks the N-terminal glutaminase (glutamine amidotransferase) domain found in glutamine-dependent enzymes (e.g., yeast Qns1, ~700 aa). Consequently it uses free ammonium from the cellular pool as the amide donor rather than generating ammonia in situ from glutamine. This contrasts with the two-domain glutamine-dependent enzyme, which "utilizes a glutamine aminotransferase domain to supply ammonia for amidation of nicotinic acid adenine dinucleotide (NaAD⁺) to NAD⁺" (Wojcik et al., 2006, PMID 16954203). (Note: many bacterial "NH₃-dependent" NadE enzymes retain some capacity to use glutamine in vitro, but the diagnostic architectural feature is the absence of a dedicated glutaminase domain; the physiological/annotated donor for Q88DF6 is ammonia.)
Cofactor requirements: ATP (hydrolyzed to AMP + PPi, characteristic of the N-type ATP pyrophosphatase superfamily) and divalent Mg²⁺ (a binuclear Mg²⁺ cluster at the ATP site).
NadE is a member of the N-type ATP pyrophosphatase / PP-loop amidotransferase superfamily. Catalysis proceeds in two chemical steps:
The mechanism is directly supported by high-resolution B. subtilis crystal structures that trapped the intermediate: the enzyme was solved "in complex with the trapped reaction intermediate NAD-adenylate" (Rizzi et al., 1998, PMID 9753692), and an atomic-resolution (1.0 Å) structure showed that "both binding sites are occupied by the NAD-adenylate intermediate, pyrophosphate and two magnesium ions," with "a mechanism … proposed for the second catalytic step, which includes a nucleophilic attack by the ammonia molecule on the intermediate" (Symersky et al., 2002, PMID 12077433).
Active-site / ligand-binding residues in Q88DF6 (UniProt features): an ATP/Mg-binding P-loop (SGGxDS motif, ⁵⁰GISGGVDS⁵⁷) and additional substrate-contacting residues at positions 56, 147, 167, 172, 180, 187, 196, 218, and 267–268. The SGGxD signature is the hallmark of the ATP-pyrophosphatase family and directly rationalizes the AMP + PPi product stoichiometry.
Evolutionary justification for transferring this mechanism (Iteration 2 analysis). Global pairwise alignment (Needleman–Wunsch) shows Q88DF6 shares 52.4% amino-acid identity (140/267 aligned positions) with the experimentally characterized E. coli NadE (UniProt P18843, 275 aa) and 48.5% identity (129/266) with the B. subtilis NAD synthetase (P08164, 272 aa) whose intermediate-trapped crystal structures defined the mechanism. All three are ~272–275 aa single-domain enzymes, and the catalytic PP-loop is conserved (Q88DF6 SGGVDS at res 52; B. subtilis SGGQDS at res 47). This level of identity across the full length, together with conservation of the catalytic motif, means the fold, active-site geometry, homodimeric assembly, and two-step adenylate chemistry established for the model enzymes apply directly to the P. putida protein. Critically, all 11 UniProt-annotated ATP/substrate-binding residues of Q88DF6 are strictly identical to their aligned positions in the B. subtilis structural enzyme (G50, D56, R147, T167, E172, K180, D187, K196, T218, H267, K268 — 11/11 conserved), confirming the active-site chemistry is preserved residue-for-residue.
Non-redundancy (Iteration 3 analysis). Proteome-wide UniProt queries of P. putida KT2440 (taxid 160488) return exactly one protein for EC 6.3.1.5, for the NAD synthetase family, and for gene nadE — Q88DF6 (PP_4869). There is no paralogous isozyme, so loss of NadE cannot be compensated, reinforcing its essential, non-redundant terminal role in NAD⁺ biosynthesis.
NAD⁺ biosynthesis in bacteria funnels multiple inputs to a common intermediate, nicotinic acid mononucleotide (NaMN), which is adenylylated by NadD (NaMN adenylyltransferase) to NaAD, and finally amidated by NadE to NAD⁺:
de novo: L-aspartate → (NadB/NadA/NadC) → NaMN
salvage: nicotinamide/nicotinic acid/NR → ... → NaMN
│
▼
NaMN --NadD--> NaAD --NadE--> NAD⁺
Because both the de novo (aspartate) route and the salvage routes converge on NaAD, NadE is the single terminal enzyme producing NAD⁺ in the cell; its activity cannot be bypassed by nicotinamide/nicotinic acid salvage. NAD⁺ (with NADH, and NADP(H) after phosphorylation by NAD kinase) is the electron carrier for respiration, redox balancing, and hundreds of biosynthetic and catabolic reactions.
Essentiality and target validation (inference from close relatives). In M. tuberculosis, NadD and NadE "were selected as promising candidate drug targets," and induced degradation of either enzyme "showed a strong bactericidal effect which coincided with anticipated changes in relative levels of NaMN and NaAD intermediates (substrates of NadD and NadE, respectively) and ultimate depletion of the NAD(H) pool," producing a metabolic catastrophe (Rodionova et al., 2014, PMID 24549842). More recent work confirms NadE (NAD synthesis) as metabolically distinct from and essential alongside NAD kinase in defining NAD(P) essentiality (Sharma et al., 2023, PMID 37350592). By strong homology and identical pathway position, NadE is expected to be essential in P. putida KT2440, where a robust NAD(H)/NADPH supply underpins the organism's noted redox-balancing systems (e.g., PntAB/SthA transhydrogenases, PMID 42335895) and industrial biotransformation capacity. Consistent with this, genome-wide transposon (Tn-seq/RB-TnSeq) studies of KT2440 build saturating libraries that disrupt "nearly all (4,778) non-essential genes" (Eng et al., 2021, PMID 33964456) — the terminal NAD-biosynthesis genes are expected to reside in the complementary essential-gene set that tolerates no insertions, although PP_4869 is not individually called out in those reports.
| Claim | Evidence type | Source |
|---|---|---|
| Reaction = ATP-dependent amidation of deamido-NAD⁺ → NAD⁺, NH₄⁺ donor, EC 6.3.1.5 | Curated annotation (HAMAP MF_00193) | UniProt Q88DF6 |
| Terminal step of NAD⁺ biosynthesis (step 1/1 from deamido-NAD⁺) | Curated pathway annotation | UniProt Q88DF6 |
| Two-step mechanism via trapped NAD-adenylate intermediate + Mg²⁺ + PPi | Atomic-resolution crystal structures (homolog) | PMID 9753692; PMID 12077433 |
| Ammonia nucleophilic attack in step 2 | Structural mechanism (homolog) | PMID 12077433 |
| Homodimer; interfacial deamido-NAD⁺ site | Curated + structural | UniProt; PMID 9753692 |
| Short NH₃-dependent form lacks glutaminase domain (vs glutamine-dependent Qns1) | Comparative/biochemical | PMID 16954203; sequence length 275 aa |
| Essential terminal enzyme / druggable, loss depletes NAD(H) | Genetic knockdown + ¹³C metabolomics (homolog) | PMID 24549842; PMID 37350592 |
| Cytoplasmic; ATP-pyrophosphatase P-loop (SGGxD, res 50–57) | Sequence/feature analysis | UniProt Q88DF6 |
| 52.4% id to E. coli NadE, 48.5% to B. subtilis NadE; PP-loop conserved | Pairwise alignment (this work) | UniProt P18843, P08164 |
| 11/11 annotated active-site residues identical to B. subtilis enzyme | Alignment residue mapping (this work) | UniProt Q88DF6, P08164 |
| Sole NAD synthetase (EC 6.3.1.5) in KT2440 — no paralog | Proteome query (this work) | UniProt taxid 160488 |
Report generated Iteration 1. Databases consulted: UniProt (Q88DF6, live REST fetch), PubMed. Key primary references: PMID 9753692, 12077433, 16954203, 24549842, 37350592.